Report cover image

Global Lurasidone Hydrochloride Generics Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 205 Pages
SKU # APRC20278952

Description

Summary

According to APO Research, the global Lurasidone Hydrochloride Generics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Lurasidone Hydrochloride Generics market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Lurasidone Hydrochloride Generics market include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lurasidone Hydrochloride Generics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lurasidone Hydrochloride Generics, also provides the sales of main regions and countries. Of the upcoming market potential for Lurasidone Hydrochloride Generics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lurasidone Hydrochloride Generics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lurasidone Hydrochloride Generics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lurasidone Hydrochloride Generics sales, projected growth trends, production technology, application and end-user industry.


Lurasidone Hydrochloride Generics Segment by Company


Chia Tai Tianqing Pharmaceutical

Zhejiang Huahai Pharmaceutical

YaoPharma

Yangtze River Pharmaceutical

SJZ No.4 Pharmaceutical

Shandong Jewim Pharmaceutical

Qilu Pharmaceutical

Hansoh Pharma

Hisun Pharmaceuticals

Cisen Pharmaceutical

Changzhou Pharmaceutical Factory

Zydus

Sun Pharmaceuticals

MSN

Lupin

Dr. Reddy's Laboratories

Amneal

Alkem

Alembic pharmaceuticals

Accord Healthcare

Lurasidone Hydrochloride Generics Segment by Type


20mg per Tablet

40mg per Tablet

60mg per Tablet

80mg per Tablet

120mg per Tablet

Lurasidone Hydrochloride Generics Segment by Application


Schizophrenia

Bipolar Depression

Lurasidone Hydrochloride Generics Segment by Region


North America


United States

Canada

Mexico

Europe


Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific


China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America


Brazil

Argentina

Chile

Middle East & Africa


Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lurasidone Hydrochloride Generics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Lurasidone Hydrochloride Generics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Lurasidone Hydrochloride Generics significant trends, drivers, influence factors in global and regions.
6. To analyze Lurasidone Hydrochloride Generics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lurasidone Hydrochloride Generics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lurasidone Hydrochloride Generics industry.
Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Lurasidone Hydrochloride Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Lurasidone Hydrochloride Generics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

205 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Lurasidone Hydrochloride Generics Sales Value (2020-2031)
1.2.2 Global Lurasidone Hydrochloride Generics Sales Volume (2020-2031)
1.2.3 Global Lurasidone Hydrochloride Generics Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Lurasidone Hydrochloride Generics Market Dynamics
2.1 Lurasidone Hydrochloride Generics Industry Trends
2.2 Lurasidone Hydrochloride Generics Industry Drivers
2.3 Lurasidone Hydrochloride Generics Industry Opportunities and Challenges
2.4 Lurasidone Hydrochloride Generics Industry Restraints
3 Lurasidone Hydrochloride Generics Market by Company
3.1 Global Lurasidone Hydrochloride Generics Company Revenue Ranking in 2024
3.2 Global Lurasidone Hydrochloride Generics Revenue by Company (2020-2025)
3.3 Global Lurasidone Hydrochloride Generics Sales Volume by Company (2020-2025)
3.4 Global Lurasidone Hydrochloride Generics Average Price by Company (2020-2025)
3.5 Global Lurasidone Hydrochloride Generics Company Ranking (2023-2025)
3.6 Global Lurasidone Hydrochloride Generics Company Manufacturing Base and Headquarters
3.7 Global Lurasidone Hydrochloride Generics Company Product Type and Application
3.8 Global Lurasidone Hydrochloride Generics Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Lurasidone Hydrochloride Generics Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Lurasidone Hydrochloride Generics Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Lurasidone Hydrochloride Generics Market by Type
4.1 Lurasidone Hydrochloride Generics Type Introduction
4.1.1 20mg per Tablet
4.1.2 40mg per Tablet
4.1.3 60mg per Tablet
4.1.4 80mg per Tablet
4.1.5 120mg per Tablet
4.2 Global Lurasidone Hydrochloride Generics Sales Volume by Type
4.2.1 Global Lurasidone Hydrochloride Generics Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Lurasidone Hydrochloride Generics Sales Volume by Type (2020-2031)
4.2.3 Global Lurasidone Hydrochloride Generics Sales Volume Share by Type (2020-2031)
4.3 Global Lurasidone Hydrochloride Generics Sales Value by Type
4.3.1 Global Lurasidone Hydrochloride Generics Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Lurasidone Hydrochloride Generics Sales Value by Type (2020-2031)
4.3.3 Global Lurasidone Hydrochloride Generics Sales Value Share by Type (2020-2031)
5 Lurasidone Hydrochloride Generics Market by Application
5.1 Lurasidone Hydrochloride Generics Application Introduction
5.1.1 Schizophrenia
5.1.2 Bipolar Depression
5.2 Global Lurasidone Hydrochloride Generics Sales Volume by Application
5.2.1 Global Lurasidone Hydrochloride Generics Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Lurasidone Hydrochloride Generics Sales Volume by Application (2020-2031)
5.2.3 Global Lurasidone Hydrochloride Generics Sales Volume Share by Application (2020-2031)
5.3 Global Lurasidone Hydrochloride Generics Sales Value by Application
5.3.1 Global Lurasidone Hydrochloride Generics Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Lurasidone Hydrochloride Generics Sales Value by Application (2020-2031)
5.3.3 Global Lurasidone Hydrochloride Generics Sales Value Share by Application (2020-2031)
6 Lurasidone Hydrochloride Generics Regional Sales and Value Analysis
6.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Lurasidone Hydrochloride Generics Sales by Region (2020-2031)
6.2.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2020-2025
6.2.2 Global Lurasidone Hydrochloride Generics Sales by Region (2026-2031)
6.3 Global Lurasidone Hydrochloride Generics Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Lurasidone Hydrochloride Generics Sales Value by Region (2020-2031)
6.4.1 Global Lurasidone Hydrochloride Generics Sales Value by Region: 2020-2025
6.4.2 Global Lurasidone Hydrochloride Generics Sales Value by Region (2026-2031)
6.5 Global Lurasidone Hydrochloride Generics Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Lurasidone Hydrochloride Generics Sales Value (2020-2031)
6.6.2 North America Lurasidone Hydrochloride Generics Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Lurasidone Hydrochloride Generics Sales Value (2020-2031)
6.7.2 Europe Lurasidone Hydrochloride Generics Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Lurasidone Hydrochloride Generics Sales Value (2020-2031)
6.8.2 Asia-Pacific Lurasidone Hydrochloride Generics Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Lurasidone Hydrochloride Generics Sales Value (2020-2031)
6.9.2 South America Lurasidone Hydrochloride Generics Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Lurasidone Hydrochloride Generics Sales Value (2020-2031)
6.10.2 Middle East & Africa Lurasidone Hydrochloride Generics Sales Value Share by Country, 2024 VS 2031
7 Lurasidone Hydrochloride Generics Country-level Sales and Value Analysis
7.1 Global Lurasidone Hydrochloride Generics Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Lurasidone Hydrochloride Generics Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
7.3.1 Global Lurasidone Hydrochloride Generics Sales by Country (2020-2025)
7.3.2 Global Lurasidone Hydrochloride Generics Sales by Country (2026-2031)
7.4 Global Lurasidone Hydrochloride Generics Sales Value by Country (2020-2031)
7.4.1 Global Lurasidone Hydrochloride Generics Sales Value by Country (2020-2025)
7.4.2 Global Lurasidone Hydrochloride Generics Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.5.2 USA Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.6.2 Canada Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.8.2 Germany Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.9.2 France Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.9.3 France Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.11.2 Italy Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.12.2 Spain Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.13.2 Russia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.16.2 China Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.16.3 China Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.17.2 Japan Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.19.2 India Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.19.3 India Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.20.2 Australia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.24.2 Chile Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.26.2 Peru Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.28.2 Israel Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.29.2 UAE Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.31.2 Iran Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Lurasidone Hydrochloride Generics Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Lurasidone Hydrochloride Generics Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Lurasidone Hydrochloride Generics Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Chia Tai Tianqing Pharmaceutical
8.1.1 Chia Tai Tianqing Pharmaceutical Comapny Information
8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
8.1.3 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.1.4 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
8.2 Zhejiang Huahai Pharmaceutical
8.2.1 Zhejiang Huahai Pharmaceutical Comapny Information
8.2.2 Zhejiang Huahai Pharmaceutical Business Overview
8.2.3 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.2.4 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
8.3 YaoPharma
8.3.1 YaoPharma Comapny Information
8.3.2 YaoPharma Business Overview
8.3.3 YaoPharma Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.3.4 YaoPharma Lurasidone Hydrochloride Generics Product Portfolio
8.3.5 YaoPharma Recent Developments
8.4 Yangtze River Pharmaceutical
8.4.1 Yangtze River Pharmaceutical Comapny Information
8.4.2 Yangtze River Pharmaceutical Business Overview
8.4.3 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.4.4 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.4.5 Yangtze River Pharmaceutical Recent Developments
8.5 SJZ No.4 Pharmaceutical
8.5.1 SJZ No.4 Pharmaceutical Comapny Information
8.5.2 SJZ No.4 Pharmaceutical Business Overview
8.5.3 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.5.4 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.5.5 SJZ No.4 Pharmaceutical Recent Developments
8.6 Shandong Jewim Pharmaceutical
8.6.1 Shandong Jewim Pharmaceutical Comapny Information
8.6.2 Shandong Jewim Pharmaceutical Business Overview
8.6.3 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.6.4 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.6.5 Shandong Jewim Pharmaceutical Recent Developments
8.7 Qilu Pharmaceutical
8.7.1 Qilu Pharmaceutical Comapny Information
8.7.2 Qilu Pharmaceutical Business Overview
8.7.3 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.7.4 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.7.5 Qilu Pharmaceutical Recent Developments
8.8 Hansoh Pharma
8.8.1 Hansoh Pharma Comapny Information
8.8.2 Hansoh Pharma Business Overview
8.8.3 Hansoh Pharma Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.8.4 Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio
8.8.5 Hansoh Pharma Recent Developments
8.9 Hisun Pharmaceuticals
8.9.1 Hisun Pharmaceuticals Comapny Information
8.9.2 Hisun Pharmaceuticals Business Overview
8.9.3 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.9.4 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
8.9.5 Hisun Pharmaceuticals Recent Developments
8.10 Cisen Pharmaceutical
8.10.1 Cisen Pharmaceutical Comapny Information
8.10.2 Cisen Pharmaceutical Business Overview
8.10.3 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.10.4 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
8.10.5 Cisen Pharmaceutical Recent Developments
8.11 Changzhou Pharmaceutical Factory
8.11.1 Changzhou Pharmaceutical Factory Comapny Information
8.11.2 Changzhou Pharmaceutical Factory Business Overview
8.11.3 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.11.4 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio
8.11.5 Changzhou Pharmaceutical Factory Recent Developments
8.12 Zydus
8.12.1 Zydus Comapny Information
8.12.2 Zydus Business Overview
8.12.3 Zydus Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.12.4 Zydus Lurasidone Hydrochloride Generics Product Portfolio
8.12.5 Zydus Recent Developments
8.13 Sun Pharmaceuticals
8.13.1 Sun Pharmaceuticals Comapny Information
8.13.2 Sun Pharmaceuticals Business Overview
8.13.3 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.13.4 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
8.13.5 Sun Pharmaceuticals Recent Developments
8.14 MSN
8.14.1 MSN Comapny Information
8.14.2 MSN Business Overview
8.14.3 MSN Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.14.4 MSN Lurasidone Hydrochloride Generics Product Portfolio
8.14.5 MSN Recent Developments
8.15 Lupin
8.15.1 Lupin Comapny Information
8.15.2 Lupin Business Overview
8.15.3 Lupin Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.15.4 Lupin Lurasidone Hydrochloride Generics Product Portfolio
8.15.5 Lupin Recent Developments
8.16 Dr. Reddy's Laboratories
8.16.1 Dr. Reddy's Laboratories Comapny Information
8.16.2 Dr. Reddy's Laboratories Business Overview
8.16.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.16.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio
8.16.5 Dr. Reddy's Laboratories Recent Developments
8.17 Amneal
8.17.1 Amneal Comapny Information
8.17.2 Amneal Business Overview
8.17.3 Amneal Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.17.4 Amneal Lurasidone Hydrochloride Generics Product Portfolio
8.17.5 Amneal Recent Developments
8.18 Alkem
8.18.1 Alkem Comapny Information
8.18.2 Alkem Business Overview
8.18.3 Alkem Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.18.4 Alkem Lurasidone Hydrochloride Generics Product Portfolio
8.18.5 Alkem Recent Developments
8.19 Alembic pharmaceuticals
8.19.1 Alembic pharmaceuticals Comapny Information
8.19.2 Alembic pharmaceuticals Business Overview
8.19.3 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.19.4 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
8.19.5 Alembic pharmaceuticals Recent Developments
8.20 Accord Healthcare
8.20.1 Accord Healthcare Comapny Information
8.20.2 Accord Healthcare Business Overview
8.20.3 Accord Healthcare Lurasidone Hydrochloride Generics Sales, Value and Gross Margin (2020-2025)
8.20.4 Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio
8.20.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Lurasidone Hydrochloride Generics Value Chain Analysis
9.1.1 Lurasidone Hydrochloride Generics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Lurasidone Hydrochloride Generics Sales Mode & Process
9.2 Lurasidone Hydrochloride Generics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Lurasidone Hydrochloride Generics Distributors
9.2.3 Lurasidone Hydrochloride Generics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.